The ides of February are dismal and dreary here in the wet and grey Pioneer Valley of Massachusetts, but we remain hopeful of the sunshine to come. What do I have to share with you, dear Irregulars, as we seek a little brightness to end the week? Well, I do have a few buys to […]
And our Annual Review proceeds apace… on a day when the market is showing signs of actually having a meaningful correction, thanks to Friday jitters and inflation worries and rising interest rates… so cross your fingers for better prices in the week to come (I did buy a couple positions this week, but as I […]
Free letter that covers “all topics within the cannabis business and investment landscape”.
Many Gumshoe readers wanted me to follow up on yesterday’s marijuana article right away, identifying the other two stocks hinted at in the ads for Nick Giambruno’s Crisis Investing… and we aim to please, so let’s jump right into it. If you missed part one, you can check that out here — the overriding argument […]
This is the headline that so many readers have been asking about in recent weeks… “URGENT: If you missed America’s ‘pot stock mania,’ here’s your second chance to become a marijuana millionaire. This 58¢ pot stock is set to soar on October 31, 2017, when Canada votes to legalize marijuana for the entire country.” That’s […]
Jimmy Mengel is pushing a new Marijuana stock, one which apparently just recently became public, for his Marijuana Manifesto service… so what is it? He calls it a “Marijuana Streaming” company, so that’s music to my ears — I’ve long had a fondness for the “free upside, limited downside” of the streaming and royalty companies […]
Jimmy Mengel has pitched pot stocks several times before, but now he’s upped the ante and is launching a marijuana-only newsletter service called The Marijuana Manifesto… which is probably as good a sign of a market top as we could hope for, but we’ll see. In launching this service, which he’s selling for about $2,000 […]
Marijuana-focused stock advisory launched by Jimmy Mengel at Angel Publishing in early 2017, he has been recommending marijuana stocks for his much less expensive Crow’s Nest advisory since 2015 or so.
Individual investors are obsessed with marijuana stocks these days, hoping to get in on pot stocks the same way Joe Kennedy got in on whiskey in the days before prohibition was lifted… so it certainly caught our readers eyes when Hilary Kramer started promoting that she has “The One Stock That Could Make You a […]
Today’s article is a lightly updated revision of one that appeared on November 3, when an earlier “pre-election” version of the same ad was running. The hints about individual stocks are the same in the ad today, as is much of the rest of the language, though back then it was an urgent “pre-election” push […]
This week I’ve got a little teaser decipherization for you to get us started, and we’ve also got a new piece from Dr. KSS… and I’ve got some updated thoughts on a few other stocks at the end of today’s piece. The teaser? Well, it’s been circulating for a few weeks now, and it caught […]
This article was originally published on December 17, it has not been edited or revised. The ad from Jimmy Mengel’s The Crow’s Nest is apparently circulating heavily again, because questions are percolating through to me about these “secret marijuana stocks” again… so we’re moving it to the top of the list today for your edutainment. […]
This tread is created for serious cannabis investors to share K.A.S.H. by providing ideas, diligence, links, equities, etc. with like-minded individuals.
“The Greatest Medical Breakthrough in 72 Years… “One Drug to End All Pain — Naturally “A new revolutionary drug called ‘Delta-9’ will send a small group of companies skyrocketing for life-altering gains… starting December 31, 2014. “The last time something like this happened 72 years ago… investors had the opportunity to turn every $1,000 into […]
Well, again Frank Curzio’s Phase 1 Investor wins the prize for “teaser ad most Gumshoe readers are asking about” … so let’s give it a gander for you. Phase 1 is a premium-priced ($3,500 is the current “on sale” cost) small cap newsletter published by Stansberry, and it tends to be among the most-requested letters […]
Who has the most experience the large Medical Companies or new upstarts. Of course Capital investment does not look like a problem.
OK. So I own a few shares of this penny stock. Up a few bucks. Would love some rational analysis of this stock. Pump and dump or a real long term winner. Based on current legislative trends in a few states and liberal federal government leanings, Marijuana looks pretty good. I like it. Please drag […]
Long time reader, few months ago subscriber, one of a very few newsletters I read, and def my most favorite. So platitudes aside, I would really love to know what we all think about existing/upcoming marijuana stocks. With mdeical pot on the rise and now with Washington/Colorado legalizing recreational use, it would seem that the […]
I was wondering what your take on the legalization on marijuana stands for investors? Any picks or suggestions on what to look for on this?